Literature DB >> 10674983

T cell transformation with Herpesvirus saimiri: a tool for neuroimmunological research.

E Meinl1, R Hohlfeld.   

Abstract

The finite life span of human T lymphocytes and their requirement of regular restimulation frequently limit human T cell studies. Once infected with H. saimiri, however, human and monkey T cells are transformed to stable growth without the need for further restimulation. H. saimiri persists in human growth-transformed T cells episomally and only a few viral genes are expressed. The release of infectious virus from transformed human T cells has not been observed. H. saimiri-transformed T cells have the phenotype of mature activated CD4+ or CD8+ T cells. Transformed T cells retain a structurally and functionally intact T cell receptor and respond specifically to recognition of their antigen. They produce Th1-like cytokines, provide B cell help, can be triggered to become cytotoxic, and are sensitive to a variety of apoptosis-inducing treatments. While H. saimiri-transformed T cells resemble native T cells in numerous aspects, their reactivity to CD2 is strikingly different: Native T cells are activated via CD2 by certain pairs of mAbs, but not by the mere binding of CD2 to its ligand CD58. In contrast, H. saimiri-transformed T cells are activated by a single crosslinked anti-CD2 mAb and also by interaction with CD58-bearing cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674983     DOI: 10.1016/s0165-5728(99)00217-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  Limited heterogeneity of T cell receptor BV usage in aplastic anemia.

Authors:  W Zeng; J P Maciejewski; G Chen; N S Young
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Characterization of Herpesvirus saimiri-transformed T lymphocytes from common variable immunodeficiency patients.

Authors:  J A Cabanillas; R Cambronero; A Pacheco-Castro; M C García-Rodríguez; J M Martín-Fernández; G Fontán; J R Regueiro
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

3.  Precise identification of a human immunodeficiency virus type 1 antigen processing mutant.

Authors:  Peter Zimbwa; Anita Milicic; John Frater; Thomas J Scriba; Antony Willis; Philip J R Goulder; Tilly Pillay; Huldrych Gunthard; Jonathan N Weber; Hua-Tang Zhang; Rodney E Phillips
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.